1. Beadling,,C. and Smith,K.A. DNA array analysis of interleukin-2-regulated immediate/early genes. Medical Immunology 1:2, 2002.
2. Blattman, J.N., Grayson, J.M., Wherry, E.J., Kaech, S.M., Smith, K,A., Ahmed, R. Therapeutic use of IL2 to enhance antiviral T cell responses in vivo. Nature Med. 9:1-8, 2003.
3. Smith, K.A. The quantal theory of how the immune system discriminates between ?self and non-self?. Med Immunol. 3:3, 2004.
4. Nasca, J., Edghill-Smith, Y., Tsai, W-P., Venzon, D., Tryniszewska, E., Hryniewicz, A., Moniuszko, M., Kinter, A., Smith, K.A., Franchini, G. Contrasting effects of low-dose IL2 on vaccine-boosted Simian Immunodeficiency Virus (SIV)-specific CD4+ and CD8+ T cells in macaques chronically infected with SIVmac251. J Immunol. 174:1913-1921, 2005.
5. Smith, K.A. The structure of IL2 bound to the three chains of the IL2 receptor and how signaling occurs. Med. Immunol. 5:3, 2006.
6. Smith, K.A., Andjelic, S., Popmihajlov, Z., Kelly-Rossini, L., Sass, A., Lesser, M., Benkert., S., Waters, C., Ruitenberg, J., Bellman, P. Immunotherapy with canarypox vaccine and interleukin-2 for HIV-1 infection: Termination of a randomized trial. PLoS Clinical Trials. January, 2007, e5